title: [Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast].
abstract: OBJECTIVE
  To study the diagnostic usefulness of immunohistochemical markers in distinguishing between invasive ductal carcinoma and invasive lobular carcinoma of breast.
  
  
  METHODS
  Twenty-four cases of grade I invasive ductal carcinoma, 12 cases of classic invasive lobular carcinoma and 14 cases of invasive carcinoma with mixed ductal and lobular features were retrieved from the archival files of Peking University First Hospital during the period from January, 1998 to December, 2001. Immunohistochemical study for E-cadherin, p120 catenin, epithelia membrane protein 1 (EMP1) and DVL1 was performed.
  
  
  RESULTS
  The positivity rates for E-cadherin in grade I invasive ductal carcinoma and classic invasive lobular carcinoma were 83.3% (20/24) and 0, respectively (P < 0.01). The positivity rates for p120 catenin were 100% in both grade 1 invasive ductal carcinoma (membranous staining) and classic invasive lobular carcinoma (cytoplasmic staining). The positivity rates for EMP1 and DVL1 in gradeI invasive ductal carcinoma were 95.8% (23/24) and 54.2% (13/24), respectively; while those in classic invasive lobular carcinoma were 12 and 5 cases, respectively.
  
  
  CONCLUSIONS
  E-cadherin and p120 catenin are useful immunomarkers for distinguishing between invasive ductal carcinoma and invasive lobular carcinoma. On the other hand, EMP1 and DVL1 are of limited value in this respect.
authors.affiliation: Department of Pathology, the First Teaching Hospital, Peking University, Beijing 100034, China. pathology123@sina.com
authors.forename: Hong-Fang
authors.initials: HF
authors.lastname: Yin
authors.forename: Ting
authors.initials: T
authors.lastname: Li
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.forename: Shuang
authors.initials: S
authors.lastname: Zhang
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D015820:Cadherins / Q000378:metabolism*; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D018275:Carcinoma, Lobular / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D051177:Catenins / Q000378:metabolism*; D003937:Diagnosis, Differential; D018572:Disease-Free Survival; D000072261:Dishevelled Proteins; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000379:methods; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D015996:Survival Rate; D000095002:Delta Catenin
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D015820:Cadherins; D051177:Catenins; C000606578:DVL1 protein, human; D000072261:Dishevelled Proteins; D009363:Neoplasm Proteins; D010750:Phosphoproteins; D011956:Receptors, Cell Surface; C097051:epithelial membrane protein-1; D000095002:Delta Catenin; C000722347:CTNND1 protein, human